Neuropeptide antagonists
US6197822A · kind A · utility
2Cited by
2References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 25, 2000 |
| Grant date | Mar 6, 2001 |
| Priority date | — |
| Expiry date | Jan 25, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The compound ##STR1## is a neuropeptide Y antagonist and is effective in treating feeding disorders, cardiovascular diseases and other physiological disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.